NEW YORK, NY / ACCESS Newswire / March 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

Fintel reports that on March 25, 2025, Raymond James upgraded their outlook for HealthEquity (NasdaqGS:HQY) from Outperform ...

Raymond James analyst Gregory Peters upgraded Healthequity (HQY – Research Report) to a Buy yesterday and set a price target of $115.00. The ...

HealthEquity's Q4 revenue beat estimates, but EPS missed. Raymond James upgraded the stock to Strong Buy, citing long-term growth despite fraud concerns.

HealthEquity reports fourth-quarter financial results after the market close on Tuesday and shares are sinking. Here's a ...

We came across a bullish thesis on HealthEquity, Inc. (HQY) on Substack by Francesco Ferrari. In this article, we will ...

HealthEquity (NASDAQ:HQY – Free Report) had its price target lowered by KeyCorp from $120.00 to $110.00 in a report issued on Monday,Benzinga reports. The firm currently has an overweight rating on ...

In this article, we are going to take a look at where HealthEquity Inc. (NASDAQ:HQY) stands against other Wednesday’s worst performers. Shares on Wall Street bounced back from a bloodbath ...

HealthEquity stock drops after mixed Q4 results despite 18.8% revenue growth. Click here to find out why HQY stock is a Hold.

Investors in HealthEquity Inc (Symbol: HQY) saw new options begin trading this week, for the April 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the HQY ...